
|Articles|February 7, 2014
Ranibizumab leading the anti-VEGF evolution
Considerations and new perspectives in anti-VEGF therapy.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement













































